A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis
Public ClinicalTrials.gov record NCT04693195. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety, and Tolerability of BLU-5937 for the Treatment of Chronic Pruritus in Adult Subjects With Atopic Dermatitis
Study identification
- NCT ID
- NCT04693195
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bellus Health Inc. - a GSK company
- Industry
- Enrollment
- 142 participants
Conditions and interventions
Conditions
Interventions
- BLU-5937 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 8, 2020
- Primary completion
- Oct 3, 2021
- Completion
- Oct 11, 2021
- Last update posted
- Oct 16, 2022
2020 – 2021
United States locations
- U.S. sites
- 28
- U.S. states
- 15
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bellus Health Investigational Site #28 | Phoenix | Arizona | 85032 | — |
| Bellus Health Investigational Site #10 | Scottsdale | Arizona | 85254 | — |
| Bellus Health Investigational Site #23 | Beverly Hills | California | 90212 | — |
| Bellus Health Investigational Site #33 | Encinitas | California | 92024 | — |
| Bellus Health Investigational Site #27 | Fountain Valley | California | 92708 | — |
| Bellus Health Investigational Site #35 | San Diego | California | 92123 | — |
| Bellus Health Investigational Site #15 | Hialeah | Florida | 33012 | — |
| Bellus Health Investigational Site #32 | Margate | Florida | 33063 | — |
| Bellus Health Investigational Site #16 | Miami | Florida | 33125 | — |
| Bellus Health Investigational Site #19 | Miami | Florida | 33136 | — |
| Bellus Health Investigational Site #17 | Sweetwater | Florida | 33172 | — |
| Bellus Health Investigational Site #24 | Savannah | Georgia | 31406 | — |
| Bellus Health Investigational Site #13 | Owensboro | Kentucky | 42301 | — |
| Bellus Health Investigational Site #38 | Baton Rouge | Louisiana | 70809 | — |
| Bellus Health Investigational Site #45 | Covington | Louisiana | 70433 | — |
| Bellus Health Investigational Site #18 | New Orleans | Louisiana | 70115 | — |
| Bellus Health Investigational Site #36 | Minneapolis | Minnesota | 55402 | — |
| Bellus Health Investigational Site #22 | Portsmouth | New Hampshire | 03801 | — |
| Bellus Health Investigational Site #34 | New York | New York | 10075 | — |
| Bellus Health Investigational Site #14 | High Point | North Carolina | 27262 | — |
| Bellus Health Investigational Site #29 | Norman | Oklahoma | 73071 | — |
| Bellus Health Investigational Site #37 | Newtown Square | Pennsylvania | 19073 | — |
| Bellus Health Investigational Site #41 | Rapid City | South Dakota | 57702 | — |
| Bellus Health Investigational Site #12 | Austin | Texas | 78759 | — |
| Bellus Health Investigational Site #31 | College Station | Texas | 77845 | — |
| Bellus Health Investigational Site #40 | San Antonio | Texas | 78213 | — |
| Bellus Health Investigational Site #11 | San Antonio | Texas | 78229 | — |
| Bellus Health Investigational Site #25 | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04693195, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 16, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04693195 live on ClinicalTrials.gov.